Fishers, IN, United States of America

Lisa A Shipley


Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Lisa A. Shipley

Introduction

Lisa A. Shipley is a prominent inventor based in Fishers, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal formulations for treating various medical conditions. With a total of 5 patents to her name, her work has the potential to impact the treatment of Alzheimer's Disease and other conditions.

Latest Patents

One of her latest patents is focused on a transdermal formulation of xanomeline. This invention provides a method for treating Alzheimer's Disease using a xanomeline transdermal formulation. The invention offers desired transdermal xanomeline patch formulations that could improve patient outcomes. Another notable patent involves a transdermal formulation aimed at treating conditions associated with muscarinic receptor modulation. This invention utilizes a specific compound, 3-4-(butylthio)-1,2,5-thiadiazol-3-yl-1-azabicyclo-2.2.2-octane, to create effective transdermal patch formulations.

Career Highlights

Throughout her career, Lisa has worked with leading companies in the pharmaceutical industry, including Eli Lilly and Company and Novo Nordisk A/S. Her experience in these organizations has allowed her to develop innovative solutions that address critical health issues.

Collaborations

Lisa has collaborated with notable professionals in her field, including Harlan E. Shannon and Kirti H. Valia. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Lisa A. Shipley is a trailblazer in the field of pharmaceutical innovations, with a focus on transdermal formulations that address significant health challenges. Her contributions continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…